Cannabidiol and Cocaine Craving/Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

August 16, 2019

Study Completion Date

August 16, 2019

Conditions
Substance Use DisorderCocaine DependenceWithdrawal From Addictive Substance; Detoxification
Interventions
DRUG

Cannabidiol

The investigators will carry out a double-blind, randomized, controlled trial comparing the effects of 92 days of 400 (only for the first 2 Days starting on the Day 2 of the study) or 800 mg CBD (subjects who report side effects with the 800mg dose will be administered the CBD 400 mg dose for the remainder of the trial) vs. placebo administration on cocaine craving and relapse in 110 cocaine-dependent subjects.

Trial Locations (1)

H2X 0A9

Centre de recherche du Centre Hospitalier de l'Université de Montréal, Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT02559167 - Cannabidiol and Cocaine Craving/Dependence | Biotech Hunter | Biotech Hunter